Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05925426 · ClinicalTrials.gov registry record

Defining The Quality Of Intraoperatively Salvaged Blood For Deformity Surgery

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
103
Enrollment target

NCT05925426 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 103 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05925426 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
103 participants
Enrollment target

Study Summary

The actual quality of Red Blood Cells (RBCs) salvaged during spinal deformity surgery has never been rigorously evaluated. To characterize the usefulness of intraoperatively salvaged RBCs in spinal deformity surgery. The study team hopes to answer the following questions: 1) What is the quality of RBCs salvaged during spine surgery? 2) Does intraoperatively transfused RBC salvage impact clinical outcomes?

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2022-07-01
Est. Completion 2023-09-30

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05925426

The ClinicalTrials.gov registry entry for NCT05925426 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05925426 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05925426 about?

NCT05925426 is a clinical study titled "Defining The Quality Of Intraoperatively Salvaged Blood For Deformity Surgery". The actual quality of Red Blood Cells (RBCs) salvaged during spinal deformity surgery has never been rigorously evaluated. To characterize the usefulness of intraoperatively salvaged RBCs in spinal deformity surgery. The study team hopes to answer the following questions: 1) What is the quality of R...

What is the current status of trial NCT05925426?

This trial is currently completed. The enrollment target is 103 participants. The study started on 2022-07-01. Estimated completion is 2023-09-30.

Who is sponsoring clinical trial NCT05925426?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.